Hunter syndrome (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hunter syndrome" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

6doi.org

2^nd place

4clinicaltrials.gov

5,225^th place

4,062^nd place

3apnews.com

129^th place

89^th place

2semanticscholar.org

11^th place

8^th place

2bbc.co.uk

8^th place

10^th place

1latercera.com

947^th place

2,635^th place

1whonamedit.com

2,888^th place

2,730^th place

1web.archive.org

1^st place

1time.com

61^st place

54^th place

1theguardian.com

12^th place

11^th place

apnews.com

Marchione, Marilyn (7 February 2019). "Tests suggest scientists achieved 1st 'in body' gene editing". AP News. Retrieved 7 February 2019.
Marchione, Marilynn (15 November 2017). "US scientists try 1st gene editing in the body". Associated Press. Retrieved 16 November 2017.
Marchione, Mailynn (5 September 2018). "Early results boost hopes for historic gene editing attempt". AP News. Retrieved 6 September 2018.

bbc.co.uk

news.bbc.co.uk

NEWS.BBC.co.uk, "Father cleared of murdering son", BBC News
NEWS.BBC.co.uk, "Review 'will clarify murder laws'" BBC News

clinicaltrials.gov

Staff (2 February 2019). "Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II". ClinicalTrials.gov. U.S. National Library of Medicine. Retrieved 7 February 2019.
"A Phase I/II, Randomized, Safety and Ascending Dose Ranging Study of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment". Clinicaltrials.gov. U.S. National Institutes of Health. 15 June 2009. Retrieved 22 July 2018.
"A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® - Results". Clinicaltrials.gov. U.S. National Institutes of Health. 31 October 2013. Retrieved 20 July 2014.
"Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment (AIM-IT)". Clinicaltrials.gov. U.S. National Institutes of Health. July 2014. Retrieved 20 July 2014.

doi.org

Wraith JE, Scarpa M, Beck M, et al. (March 2008). "Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy". Eur. J. Pediatr. 167 (3): 267–77. doi:10.1007/s00431-007-0635-4. PMC 2234442. PMID 18038146.
Schwartz, Ida VD (2007). "A clinical study of 77 patients with mucopolysaccharidosis type II". Acta Paediatrica. 96 (455): 63–70. doi:10.1111/j.1651-2227.2007.00212.x. PMID 17391446. S2CID 23119106.
Muenzer, J; Wraith, JE; Beck, M; Giugliani, R; Harmatz, P; Eng, CM; Vellodi, A; Martin, R; Ramaswami, U; Gucsavas-Calikoglu, M; Vijayaraghavan, S; Wendt, S; Puga, AC; Ulbrich, B; Shinawi, M; Cleary, M; Piper, D; Conway, AM; Kimura, A (August 2006). "A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)". Genetics in Medicine. 8 (8): 465–73. doi:10.1097/01.gim.0000232477.37660.fb. PMID 16912578.
Guffon, N (May 2009). "Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years". Journal of Pediatrics. 154 (5): 733–737. doi:10.1016/j.jpeds.2008.11.041. PMID 19167723.
Young ID, Harper PS (1982). "Incidence of Hunter's syndrome". Hum. Genet. 60 (4): 391–2. doi:10.1007/BF00569230. PMID 6809596. S2CID 9667145.
Hunter, C. A. (1917). "A Rare Disease in Two Brothers". Proceedings of the Royal Society of Medicine. 10 (Sect Study Dis Child). London: 104–116. doi:10.1177/003591571701001833. PMC 2018097. PMID 19979883.

latercera.com

LaTercera.com (in Spanish)^{[permanent dead link‍]}

nih.gov

pubmed.ncbi.nlm.nih.gov

Wraith JE, Scarpa M, Beck M, et al. (March 2008). "Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy". Eur. J. Pediatr. 167 (3): 267–77. doi:10.1007/s00431-007-0635-4. PMC 2234442. PMID 18038146.
Schwartz, Ida VD (2007). "A clinical study of 77 patients with mucopolysaccharidosis type II". Acta Paediatrica. 96 (455): 63–70. doi:10.1111/j.1651-2227.2007.00212.x. PMID 17391446. S2CID 23119106.
Muenzer, J; Wraith, JE; Beck, M; Giugliani, R; Harmatz, P; Eng, CM; Vellodi, A; Martin, R; Ramaswami, U; Gucsavas-Calikoglu, M; Vijayaraghavan, S; Wendt, S; Puga, AC; Ulbrich, B; Shinawi, M; Cleary, M; Piper, D; Conway, AM; Kimura, A (August 2006). "A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)". Genetics in Medicine. 8 (8): 465–73. doi:10.1097/01.gim.0000232477.37660.fb. PMID 16912578.
Guffon, N (May 2009). "Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years". Journal of Pediatrics. 154 (5): 733–737. doi:10.1016/j.jpeds.2008.11.041. PMID 19167723.
Annibali, R (October 2013). "Hunter syndrome (Mucopolysaccharidosis type II), severe phenotype: long term follow-up on patients undergone to hematopoietic stem cell transplantation". Vol. 65, no. 5. Minerva Pediatrica. pp. 487–496. PMID 24056375.
Young ID, Harper PS (1982). "Incidence of Hunter's syndrome". Hum. Genet. 60 (4): 391–2. doi:10.1007/BF00569230. PMID 6809596. S2CID 9667145.
Hunter, C. A. (1917). "A Rare Disease in Two Brothers". Proceedings of the Royal Society of Medicine. 10 (Sect Study Dis Child). London: 104–116. doi:10.1177/003591571701001833. PMC 2018097. PMID 19979883.

ncbi.nlm.nih.gov

Wraith JE, Scarpa M, Beck M, et al. (March 2008). "Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy". Eur. J. Pediatr. 167 (3): 267–77. doi:10.1007/s00431-007-0635-4. PMC 2234442. PMID 18038146.
Hunter, C. A. (1917). "A Rare Disease in Two Brothers". Proceedings of the Royal Society of Medicine. 10 (Sect Study Dis Child). London: 104–116. doi:10.1177/003591571701001833. PMC 2018097. PMID 19979883.

ninds.nih.gov

"Mucopolysaccharidoses Fact Sheet". National Institute of Neurological Disorders and Stroke. 15 November 2017. Retrieved 11 May 2018.

semanticscholar.org

api.semanticscholar.org

Schwartz, Ida VD (2007). "A clinical study of 77 patients with mucopolysaccharidosis type II". Acta Paediatrica. 96 (455): 63–70. doi:10.1111/j.1651-2227.2007.00212.x. PMID 17391446. S2CID 23119106.
Young ID, Harper PS (1982). "Incidence of Hunter's syndrome". Hum. Genet. 60 (4): 391–2. doi:10.1007/BF00569230. PMID 6809596. S2CID 9667145.

theguardian.com

Guardian.co.uk, "Former SAS soldier who smothered terminally ill son walks free" The Guardian

time.com

Marchione, Marilynne (14 November 2017). "Scientists Attempt First Gene Editing Inside a Patient". Time. Archived from the original on 15 November 2017. Retrieved 15 November 2017.

web.archive.org

Marchione, Marilynne (14 November 2017). "Scientists Attempt First Gene Editing Inside a Patient". Time. Archived from the original on 15 November 2017. Retrieved 15 November 2017.

whonamedit.com

Hunter's syndrome (Charles A. Hunter) at Who Named It?